This impaired or dysregulated hepatic IRE1α/XBP1 pathway expression is consistent with previously reported findings in murine models of cholestasis and murine and human fatty liver disease [12, 15, 23, 25]. The gene discussed is XBP1; the disease is fatty liver disease.